Yüklüyor......

Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: A Consecutive Patient Series that Illustrates the Need for Rigorous Palliative Trials

PURPOSE: Rash is the most common side effect of epidermal growth factor receptor (EGFR) inhibitors and negatively impacts quality of life. This single-institution study sought to explore how rash is currently managed outside a clinical trial setting and to further characterize general clinical aspec...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Solomon, Benjamin M., Jatoi, Aminah
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mary Ann Liebert, Inc. 2011
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3037800/
https://ncbi.nlm.nih.gov/pubmed/21226620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jpm.2010.0258
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!